NeuroBionics

About:

NeuroBionics is a biotech company focused on neurological disorders.

Top Investors: Three Arch Partners, Sprout Group

Description:

NeuroBionics Corp. researches and develops medical devices for the treatment of neurological disorders such as Parkinson’s disease, epilepsy, obesity, and depression.

Total Funding Amount:

$6M

Headquarters Location:

Seattle, Washington, United States

Founded Date:

Founders:

Number of Employees:

Last Funding Date:

2004-12-22

IPO Status:

Private

Industries: